000			01483 a2200397 4500
005			20250516144603.0
264		0	_c20131204
008			201312s 0 0 eng d
022			_a1556-679X
024	7		_a10.1128/CVI.00758-12 _2doi
040			_aNLM _beng _cNLM
100	1		_aFloden, Angela M
245	0	0	_aEvaluation of RevA, a fibronectin-binding protein of Borrelia burgdorferi, as a potential vaccine candidate for lyme disease. _h[electronic resource]
260			_bClinical and vaccine immunology : CVI _cJun 2013
300			_a892-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAnimals
650	0	4	_aAntibodies, Bacterial _xtherapeutic use
650	0	4	_aBacterial Load
650	0	4	_aBacterial Outer Membrane Proteins _ximmunology
650	0	4	_aBacterial Vaccines _xadministration & dosage
650	0	4	_aDisease Models, Animal
650	0	4	_aFemale
650	0	4	_aImmunization, Passive
650	0	4	_aLyme Disease _ximmunology
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Inbred C3H
650	0	4	_aTreatment Outcome
650	0	4	_aVaccines, Synthetic _xadministration & dosage
700	1		_aGonzalez, Tammy
700	1		_aGaultney, Robert A
700	1		_aBrissette, Catherine A
773	0		_tClinical and vaccine immunology : CVI _gvol. 20 _gno. 6 _gp. 892-9
856	4	0	_uhttps://doi.org/10.1128/CVI.00758-12 _zAvailable from publisher's website
999			_c22678388 _d22678388